These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 2146081)
1. Will 99mTc-MAG3 replace 131I-OIH and 99mTc-DTPA in the follow-up of renal transplants? Dubovsky EV; Russell CD; Yester MV; Thorstad BL; Ryan JP Contrib Nephrol; 1990; 79():118-22. PubMed ID: 2146081 [No Abstract] [Full Text] [Related]
2. [Functional parameters calculated by 99mTc-MAG3 in transplanted kidney]. Koizumi K; Yamaguchi M; Tooyama K; Uchiyama G; Yamada Y; Ueno A Kaku Igaku; 1994 Jan; 31(1):17-25. PubMed ID: 8309107 [TBL] [Abstract][Full Text] [Related]
4. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function]. Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030 [TBL] [Abstract][Full Text] [Related]
5. Transplant renography: 99m-Tc-DTPA versus 99m-Tc-MAG3. A preliminary note. Fraile M; Castell J; Buxeda M; Cuartero A; Cantarell C; Domenech-Torné FM Eur J Nucl Med; 1989; 15(12):776-9. PubMed ID: 2533892 [TBL] [Abstract][Full Text] [Related]
6. [Advantages of the new radiopharmaceutic agent, 99mTC-mercaptoacetyltriglycine (99mTc-MAG3), in the diagnosis of kidneydiseases. A comparative study with 131I-OIH, 99mTc-DTPA and 99mTc-DMSA]. Lepej J; Marosová A; Kliment J; Buchanec J; Svitác J; Klisenbauer L Bratisl Lek Listy; 1992 May; 93(5):258-65. PubMed ID: 1327424 [TBL] [Abstract][Full Text] [Related]
7. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys]. Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251 [TBL] [Abstract][Full Text] [Related]
8. Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies. Stabin M; Taylor A; Eshima D; Wooter W J Nucl Med; 1992 Jan; 33(1):33-40. PubMed ID: 1530968 [TBL] [Abstract][Full Text] [Related]
9. [Phase 3 clinical study of 99mTc-MAG3 injectable, a dynamic renal imaging agent--comparison with 123I-OIH and 99mTc-DTPA]. Torizuka K; Ishibashi A; Ikekubo K; Yamamoto K; Nishibuchi S Kaku Igaku; 1994 Feb; 31(2):183-98. PubMed ID: 8121074 [TBL] [Abstract][Full Text] [Related]
10. Comparison of 99Tcm-mercaptoacetyltriglycine and 131I-orthoiodohippurate in determination of effective renal plasma flow (ERPF). Abdel-Dayem HM; Sadek S; al-Bahar R; Sabha M; el-Sayed M Nucl Med Commun; 1989 Feb; 10(2):99-107. PubMed ID: 2525236 [TBL] [Abstract][Full Text] [Related]
12. Quantitation of renal function using MAG3. Russell CD; Dubovsky EV J Nucl Med; 1991 Nov; 32(11):2061-3. PubMed ID: 1834813 [No Abstract] [Full Text] [Related]
13. Measurements of 99mTc-MAG3 uptake in renal transplant recipients. Oei HY; Surachno S; Wilmink JM; van der Schoot JB Contrib Nephrol; 1990; 79():113-7. PubMed ID: 2146080 [No Abstract] [Full Text] [Related]
14. Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique. Prenen JA; de Klerk JM; van het Schip AD; van Rijk PP J Nucl Med; 1991 Nov; 32(11):2057-60. PubMed ID: 1834812 [TBL] [Abstract][Full Text] [Related]
15. [Analysis of renograms with simultaneous injection of 99mTc-DTPA and 131I-OIH--estimation of GFR, ERPF and retention function of individual kidney]. Maeda M; Hasegawa R; Tanaka S; Yoshida H Kaku Igaku; 1985 Sep; 22(9):1341-52. PubMed ID: 3910897 [No Abstract] [Full Text] [Related]
16. [Evaluation of renal function using 99mTc-MAG3: comparison with 123I-OIH and 99mTc-DTPA]. Takayama T; Aburano T; Shuke N; Yokoyama K; Michigishi T; Sun BF; Tonami N; Hisada K; Takabatake T; Ohta H Kaku Igaku; 1993 Jul; 30(7):753-60. PubMed ID: 8377298 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of renal function using 99mTc-MAG3 comparison with 131I-OIH by simultaneous dual energy peak acquisition method]. Hashimoto T; Matsumoto K; Ishibashi R; Iwasaki R; Sanmiya T; Hashimoto J; Kunieda E; Nakamura K; Kubo A Kaku Igaku; 1995 Feb; 32(2):139-46. PubMed ID: 7715099 [TBL] [Abstract][Full Text] [Related]
18. Tc-99m MAG3 as an alternative to Tc-99m DTPA and I-131 Hippuran for renal transplant evaluation. O'Malley JP; Ziessman HA; Chantarapitak N Clin Nucl Med; 1993 Jan; 18(1):22-9. PubMed ID: 8422715 [TBL] [Abstract][Full Text] [Related]
19. Technetium-99m DTPA dimethyl ester: a renal function imaging agent. Comparative studies in animals with technetium-99m mercaptoacetyl triglycine and 131I-ortho-iodohippurate. Bhowal K; Bhattacharyya S; Majumdar A; Giri C; Vanaja R; Ramamoorthy N; Ganguly S; Sarkar BR; Banerjee S; Chatterjee Debnath M Nucl Med Commun; 2003 May; 24(5):583-95. PubMed ID: 12717078 [TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of renal function study using 99mTc-DTPA--comparative study with 111In-DTPA and 123I-OIH]. Honda M; Tomonobu M; Kanao K; Miyauchi T; Kamibayashi K; Ota N; Matsuyuki Y Radioisotopes; 1984 Jul; 33(7):463-6. PubMed ID: 6390542 [No Abstract] [Full Text] [Related] [Next] [New Search]